The patient was diagnosed with high tumor burden and castration-naïve metastatic PCa and treated with a combination regimen of androgen deprivation therapy, docetaxel, and darolutamide, resulting in significant reduction in prostate-specific antigen levels. Here, KLK3 is linked to posterior cortical atrophy.